PI3K/Akt/mTOR-IN-5
PI3K/Akt/mTOR-IN-5 (compound D3) is a derivative of Pseudolaric Acid B with anti-tumor activity. PI3K/Akt/mTOR-IN-5 inhibits excessive proliferation of tumor cells through the PI3K/AKT/mTOR and STAT3/GPX4 pathways. PI3K/Akt/mTOR-IN-5 effectively inhibits EDU positivity, reduces colony formation, places HCT-116 cells in the S phase and G2/M phase, and induces apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Akt; Apoptosis; mTOR; PI3K; STAT
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3k-akt-mtor-in-5.html
Smiles
O=C(C1=CC[C@@]([C@@](CC1)(OC(C)=O)[C@]2([H])[C@](/C=C/C=C(C)/C(NCCN3CCCCC3)=O)(C)O4)(CC2)C4=O)OC
Molecular Formula
C30H42N2O7
Molecular Weight
542.66
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD35 / CR1 (E11), CF647 conjugate, 0.1mg/mL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Histone H1 (1415-1), CF488A conjugate, 0.1mg/mL
